Satish Cuddapah, MD
Family Medicine · Sandy Springs, GANPI 1265538854
Payments from drug & device makers
Across 174 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$2K
- Supernus Pharmaceuticals, Inc.$386
- Pfizer$115
- Eisai Inc.$97
- Boston Scientific$76
- Biohaven Pharmaceuticals, Inc.$45
- plus $180 from 10 others
What the payments were for
- Food & beverage$2,762100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 111 | $1,863 |
| Supernus Pharmaceuticals, Inc. | 33 | $386 |
| Pfizer | 7 | $115 |
| Eisai Inc. | 7 | $97 |
| Boston Scientific | 3 | $76 |
| Biohaven Pharmaceuticals, Inc. | 3 | $45 |
| Johnson & Johnson | 1 | $39 |
| Phadia US Inc. | 1 | $24 |
| Merz North America, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Harmony Biosciences LLC | 1 | $14 |
| Dermira, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tirosint$125
How this compares
$2,762 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Np ThyroidThyroid,pork | 19 | $1,019 |
| Liothyronine Sodium | 21 | $602 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $498 |
| Tramadol Hcl | 38 | $291 |
| Gabapentin | 19 | $222 |
| Metoprolol Succinate | 17 | $169 |
| Ondansetron Hcl | 12 | $141 |
| Clonazepam | 20 | $124 |
| Carisoprodol | 20 | $115 |
| Metformin Hcl | 14 | $115 |
| Alprazolam | 51 | $114 |
| Trazodone Hcl | 25 | $95 |
| Levothyroxine Sodium | 20 | $80 |
| Losartan Potassium | 12 | $80 |
| Zolpidem Tartrate | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Sandy Springs
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.